A STUDY ON LOCAL INJECTION OF METHYLPREDNISOLONE ACETATE TO PREVENT SEROMA FORMATION AFTER MASTECTOMY IN 210 CASES.
Main Article Content
Keywords
Steroid, Inflammation, Bacterial, Post-Mastectomy Seroma, Surgical, Prophylaxis, Cytokines
Abstract
The inflammatory process of seroma production, the most common postoperative complication following mastectomy, may be prevented with the use of local steroid injections. The impact of local steroid injection on seroma development was the focus of this research. This research compared the effects of saline on seroma development after mastectomy with those of a single 80 mg dose of methylprednisolone in a double-blind, randomised, placebo-controlled intervention trial. Mastectomy plus sentinel lymph node biopsy (M + SLNB) or mastectomy plus level I–II axillary lymph node dissection (M + ALND) were the more specific categories into which patients were placed based on the surgical axillary procedure. After the drain was removed on the first postoperative day, medications were introduced into the wound cavity via the drain hole. While the occurrence of side effects and problems were considered secondary objectives, seroma development constituted the main goal. In all, 210 women with primary breast cancer who were planned to have a mastectomy were considered. Following M + SLNB, a seroma formed in 32 out of 69 women (46 percent) in the group treated with methylprednisolone, compared to 52 out of 67 women (78 percent) in the group treated with saline (P < 0.001). In the intention-to-treat population, the methylprednisolone group had a much smaller mean cumulative seroma volume during the first 10 and 30 days. Methylprednisolone did not significantly affect seroma formation after M + ALND, and both the saline and methylprednisolone groups saw equal rates of seroma development. The infection rate was not different. The first day after M + SLNB, methylprednisolone was injected into the wound cavity. For the next 30 days, it significantly reduced the likelihood of seroma development. There was no such impact in the M + ALND group. More research is needed to determine whether greater or repeated dosages of methylprednisolone improve effectiveness.
References
2. Kuroi K, Shimozuma K, Taguchi T et al. Evidence-based risk factors for seroma formation in breast surgery. Jpn J ClinOncol 2016;36:197-206.
3. Baker EA, Leaper DJ: Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 2020;8:392-8.
4. DoolinEJ, Tsuno K, Strande LF et al. Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Ann OtolRhinolLaryngol2017;107:275-9.
5. Mettler L, Salmassi A, Heyer M et al. Perioperative levels of interleukin 1 beta and interleukin-6 in women with breast cancer. Clin Exp Obstet Gynecol 201931:20-2.
6. Yilmaz KB, Dogan L, Nalbant H, Akinci M, Karaman N,OzaslanCetal. Comparing scalpel, electrocautery and ultrasonic dissector effects: the impact on wound complications and pro-inflammatory cytokine levels in wound fluid from mastectomy patients. J BreastCancer 2021;14: 58–63.
7. Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast2018; 12: 338–341.
8. AgrawalA, AyantundeAA, CheungKL.Concepts of seroma formation and prevention in breast cancer surgery. ANZJ Surg2016;76:1088–1095.
9. McCaul JA, Aslaam A, Spooner RJ, Louden I, Cavanagh T,PurushothamAD. Aetiology of seroma formation in patients undergoing surgery for breast cancer.Breast 2020; 9:144–148.
10. Baker EA, Kumar S, Melling AC, Whetter D, Leaper DJ.Temporal and quantitative profiles of growth factors and metalloproteinases in acute wound fluid after mastectomy.WoundRepair Regen 2018; 16: 95–101.
11. SchulzeS, AndersenJ, OvergaardH, NørgardP, NielsenHJ, Aasen A etal. Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg2020; 132: 129–135.
12. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications.J Am Coll Surg 2022;195:694–712.
13. Berberich T, Haecker FM, Kehrer B, Erb TO, Günthard J,HammerJetal. Postpericardiotomy syndrome after minimally invasive repair of pectus excavatum.J Pediatr Surg2017; 39: e1–e3.
14. ParkGM, LeeJY, KimYG, BooSJ, Song JM,KangDHetal. Recurrent postoperative effusive–constrictive pericarditis associated with steroid discontinuation. J Cardiovasc Ultrasound2019;17:102–105.
15. Taghizadeh R, Shoaib T, Hart AM, Weiler-Mithoff EM. Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site. J Plast Reconstr Aesthet Surg2018; 61: 636–642.
16. Axelsson CK, Quamme GM, Lanng C, Szecsi PB,Mortensen MB, Wegeberg B et al. Local injection of methylprednisolone acetate to prevent seroma formation after mastectomy. Dan Med J 2022; 59: A4482.
17. KuroiK, ShimozumaK, TaguchiT, ImaiH, YamashiroH, Ohsumi Setal. Evidence-based risk factors for seroma formation in breast surgery.Jpn J Clin Oncol2016;36:197–206.
18. Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. JBreast Cancer 2022; 15: 373–380.
19. Somers RG, Jablon LK, Kaplan MJ, Sandler GL,Rosenblatt NK. The use of closed suction drainage afterlumpectomy and axillary node dissection for breast cancer.A prospective randomized trial.Ann Surg 2022;215:146–149.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Nischal Raj L
MBBS., MS., FMAS., MCH (surgical oncology), Consultant surgical Oncologist, Clear Medi Radiant Hospital, Vijay Nagar 3rd Stage, Mysore, Karnataka 570017.
Dr. Adnan Saeed
MBBS., MS.,MCH (surgical oncology),Consultant surgical Oncologist, Clear Medi Radiant Hospital, Vijay Nagar 3rd Stage, Mysore, Karnataka 570017
Dr. Arpitha M R
MBBS, MD, Senior Resident, Department of Biochemistry, JSS Medical College, Mysore.
Dr. Sumalatha A
MBBS, MD, DM, Consultant critical care Physician, Clear Medi Radiant Hospital, Vijay Nagar 3rd Stage, Mysore, Karnataka 570017.
Dr. Avinash T R
MBBS., MS (General Surgery), Assistant Consultant, Dept of oncosurgery, Clear Medi Radiant Hospital, Vijay Nagar 3rd Stage, Mysore, Karnataka 570017.